Showing results (341-350 of 350) with videos related to
Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 350 results.
Blood|July 16, 2026
First-line ibrutinib plus venetoclax for non-blastoid mantle cell lymphoma in patients ≥65 years or with TP53 mutationsMichael Wang, Marc S Hoffmann, Tomasz Wróbel, et al.Blood|February 23, 2022
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohortConstantine S Tam, John N Allan, Tanya Siddiqi, et al.American Journal of Hematology|September 13, 2019
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphomaTalha Munir, Jennifer R Brown, Susan O'Brien, et al.BMC Cancer|November 3, 2023
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 studyDo-Youn Oh, Maria Alsina Maqueda, David I Quinn, et al.European Journal of Cancer (Oxford, England : 1990)|November 11, 2018
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trialLi-Tzong Chen, Jens T Siveke, Andrea Wang-Gillam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2021
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE StudyWilliam G Wierda, John N Allan, Tanya Siddiqi, et al.Nature|April 9, 2025
Transforming ceria into 2D clusters enhances catalytic activityKonstantin Khivantsev, Hien Pham, Mark H Engelhard, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 12, 2017
Critical care admission of South African (SA) surgical patients: Results of the SA Surgical Outcomes StudyDavid Lee Skinner, Kim De Vasconcellos, Robert Wise, et al.The Lancet. Oncology|April 20, 2020
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trialJacobus Pfisterer, Catherine M Shannon, Klaus Baumann, et al.Physical Review Letters|April 6, 2001
Event-by-event fluctuations of the Kaon-to-Pion ratio in central Pb+Pb collisions at 158 GeV per nucleonS V Afanasiev, T Anticic, J Bächler, et al.Pageof 35